CFD: A Drug Target / Disease Biomarker (G1675)

Target Name: CFD

NCBI ID: G1675

Content of Review Report on CFD Target / Biomarker

CFD

CFD: A Drug Target / Disease Biomarker

CFD, or Cholesterol Fractional Density, is a protein that is expressed in the liver and kidneys and is involved in the regulation of cholesterol levels in the body. It is a type of biomarker that has been identified as a potential drug target for the treatment of various diseases, including cardiovascular disease and diabetes.

CFD is a protein that is expressed in the liver and kidneys and is involved in the regulation of cholesterol levels in the body. It is made up of four different chains of proteins, which are held together by disulfide bonds. These chains include an alpha chain, a beta chain, a gamma chain, and an delta chain. CFD is typically produced in the liver and kidneys and is involved in the regulation of cholesterol levels in the body.

One of the key functions of CFD is its role in cholesterol metabolism. CFD helps to break down and remove cholesterol from the body, which is important for maintaining good health and preventing the development of diseases such as heart disease and diabetes.

CFD is also involved in the regulation of inflammation in the body. It has been shown to play a key role in the regulation of immune responses and has been linked to the development of various inflammatory diseases.

In addition to its role in cholesterol metabolism and inflammation, CFD is also involved in the regulation of cell signaling. It has been shown to play a key role in the regulation of cellular signaling pathways, which are important for the development and progression of many diseases.

CFD is a protein that has been identified as a potential drug target for the treatment of various diseases, including cardiovascular disease and diabetes. Studies have shown that CFD has the potential to be a valuable tool for the treatment of these diseases, as it has been shown to play a key role in the regulation of cholesterol levels, inflammation, and cellular signaling.

In conclusion, CFD is a protein that is expressed in the liver and kidneys and is involved in the regulation of cholesterol levels, inflammation, and cell signaling. It has been shown to play a key role in the development and progression of various diseases, including cardiovascular disease and diabetes. As a result, CFD has the potential to be a valuable drug target for the treatment of these diseases. Further research is needed to fully understand the role of CFD in the regulation of cholesterol levels and other aspects of health, as well as its potential as a drug target.

Protein Name: Complement Factor D

Functions: Factor D cleaves factor B when the latter is complexed with factor C3b, activating the C3bbb complex, which then becomes the C3 convertase of the alternate pathway. Its function is homologous to that of C1s in the classical pathway

The "CFD Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about CFD comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets